Reset filters
  • 25 July 2007

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero

Read the article
  • 25 July 2007

IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia

Read the article
  • 25 July 2007

IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil

Read the article
  • 25 July 2007

IAS: Maraviroc slightly less effective but more tolerable in treatment-naive patients

Read the article
  • 24 July 2007

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

Read the article
  • 24 July 2007

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

Read the article
  • 24 July 2007

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

Read the article
  • 24 July 2007

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

Read the article
  • 24 July 2007

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.